Investment Type: Venture Capital
Investment Stage: Series A
Portfolio 1
Mentions in press and media 15
Date | Title | Description | Source |
30.10.2017 | Kymera Therapeutics Raises $30M In Series A | Kymera Therapeutics LLC today announced a $30M Series A Financing round to advance a transformationa... | citybizlis... |
01.12.2015 | Eli Lilly’s venture arm invests in $25M round for Symic Biom... | “We’re pretty unique in our approach to this,” Horne said. “It’s equally exciting and challenging.” ... | medcitynew... |
01.12.2015 | Daily funding roundup - December 1, 2015 | AppDynamics raised $158M; Symic secured $25M; Deskbookers announced $1.6M funding Deskbookers, an o... | vator.tv/n... |
19.07.2015 | Easy pill to swallow: Aussie biotech startup raises $40 mill... | A biotech startup spun out of the University of Queensland has raised $40 million to help develop a ... | smartcompa... |
24.06.2014 | Numerate Completes $8M Financing Round | Numerate, Inc., a San Bruno, CA-based biotechnology company, completed an $8m financing. The round ... | finsmes.co... |
10.01.2013 | Investors have put $15.5M behind cancer drug startup to revi... | Here’s what we’ve learned about Esanex since May: It’s apparently a resurrection of Serenex, a North... | medcitynew... |
02.05.2012 | Pharma startup led by Lilly Ventures execs raises $4.6 milli... | Esanex, which was formed in 2011, is apparently keeping details of its technology under wraps for no... | medcitynew... |
15.12.2011 | Cerulean Pharma Closes $15m Series D Financing | Cerulean Pharma Inc., a Cambridge, Massachusetts-based designer and developer of nanopharmaceuticals... | finsmes.co... |
28.06.2011 | Nimbus Discovery Closes $24M Series A Financing | Nimbus Discovery LLC, a biopharmaceutical company that is applying advances in computer-based drug d... | finsmes.co... |
11.06.2009 | Sans IPO, Bayhill secures $350M in Genentech licensing deal | Months after giving up on its IPO hopes last year — when the market was especially brutal for lifesc... | venturebea... |
Show more